Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Bio Systems
|
September 14, 2017
Toward a hierarchical virtual screening and toxicity risk analysis for identifying novel CA XII inhibitors
Elmira Nazarshodeh, Sajjad Gharaghani
Frontiers in Pharmacology
|
August 1, 2025
Improving synergistic drug combination prediction with signature-based gene expression features in oncology
Mozhgan Mozaffarilegha, Sajjad Gharaghani
Bioorganic & Medicinal Chemistry
|
September 18, 2007
A novel QSAR model for prediction of apoptosis-inducing activity of 4-aryl-4-H-chromenes based on support vector machine
Mohammad Hossein Fatemi, Sajjad Gharaghani
Journal of Biomolecular Structure & Dynamics
|
December 5, 2022
Identification of new potent agonists for toll-like receptor 8 by virtual screening methods, molecular dynamics simulation, and MM-GBSA
Farideh Sadeghkhani, Zahra Hajihassan, Sajjad Gharaghani
Iranian Journal of Biotechnology
|
September 2, 2024
Docking-Based Virtual Screening Method for Selecting Natural Compounds with Synergistic Inhibitory Effects Against Cancer Signalling Pathways Using a Multi-Target Approach
Negar Sardarpour, Zahra Goodarzi, Sajjad Gharaghani
Heliyon
|
April 23, 2021
Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors
Nathalie Moussa, Ahmad Hassan, Sajjad Gharaghani
Current Drug Discovery Technologies
|
March 26, 2020
Novel and Predictive QSAR Model for Steroidal and Nonsteroidal 5α- Reductase Type II Inhibitors
Huda Mando, Ahmad Hassan, Sajjad Gharaghani
Chemical Biology & Drug Design
|
July 16, 2011
A structure-based QSAR and docking study on imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4,]benzodiazepines as Selective GABA(A) α5 inverse agonists
Sajjad Gharaghani, Taghi Khayamian, Fatemeh Keshavarz
Plos One
|
December 14, 2021
Structural systems pharmacology: A framework for integrating metabolic network and structure-based virtual screening for drug discovery against bacteria
Elmira Nazarshodeh, Sayed-Amir Marashi, Sajjad Gharaghani
Current Drug Discovery Technologies
|
November 14, 2019
<i>In Silico</i> Drug-designing Studies on Sulforaphane Analogues: Pharmacophore Mapping, Molecular Docking and QSAR Modeling
Neda Vaghefinezhad, Samaneh Fazeli Farsani, Sajjad Gharaghani
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Bio Systems
|
September 14, 2017
Toward a hierarchical virtual screening and toxicity risk analysis for identifying novel CA XII inhibitors
Elmira Nazarshodeh, Sajjad Gharaghani
Frontiers in Pharmacology
|
August 1, 2025
Improving synergistic drug combination prediction with signature-based gene expression features in oncology
Mozhgan Mozaffarilegha, Sajjad Gharaghani
Bioorganic & Medicinal Chemistry
|
September 18, 2007
A novel QSAR model for prediction of apoptosis-inducing activity of 4-aryl-4-H-chromenes based on support vector machine
Mohammad Hossein Fatemi, Sajjad Gharaghani
Journal of Biomolecular Structure & Dynamics
|
December 5, 2022
Identification of new potent agonists for toll-like receptor 8 by virtual screening methods, molecular dynamics simulation, and MM-GBSA
Farideh Sadeghkhani, Zahra Hajihassan, Sajjad Gharaghani
Iranian Journal of Biotechnology
|
September 2, 2024
Docking-Based Virtual Screening Method for Selecting Natural Compounds with Synergistic Inhibitory Effects Against Cancer Signalling Pathways Using a Multi-Target Approach
Negar Sardarpour, Zahra Goodarzi, Sajjad Gharaghani
Heliyon
|
April 23, 2021
Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors
Nathalie Moussa, Ahmad Hassan, Sajjad Gharaghani
Current Drug Discovery Technologies
|
March 26, 2020
Novel and Predictive QSAR Model for Steroidal and Nonsteroidal 5α- Reductase Type II Inhibitors
Huda Mando, Ahmad Hassan, Sajjad Gharaghani
Chemical Biology & Drug Design
|
July 16, 2011
A structure-based QSAR and docking study on imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4,]benzodiazepines as Selective GABA(A) α5 inverse agonists
Sajjad Gharaghani, Taghi Khayamian, Fatemeh Keshavarz
Plos One
|
December 14, 2021
Structural systems pharmacology: A framework for integrating metabolic network and structure-based virtual screening for drug discovery against bacteria
Elmira Nazarshodeh, Sayed-Amir Marashi, Sajjad Gharaghani
Current Drug Discovery Technologies
|
November 14, 2019
<i>In Silico</i> Drug-designing Studies on Sulforaphane Analogues: Pharmacophore Mapping, Molecular Docking and QSAR Modeling
Neda Vaghefinezhad, Samaneh Fazeli Farsani, Sajjad Gharaghani
Page
of 6